Zydus Lifesciences Completes Sunshine Healthcare Lanka Joint Venture

Zydus Lifesciences Limited has announced the successful completion of its transaction to subscribe to 50% of the total paid-up equity share capital of Zydus Sunshine Lifesciences (Private) Limited. This transaction establishes Zydus Sunshine as a 50:50 joint venture between Zydus Lifesciences and Sunshine Healthcare Lanka Limited. The completion date was November 11, 2026, following an extension from the initially expected completion within 90 working days from June 26, 2026. The delay in intimation was attributed to office holidays during the festive season.